Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.36 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.34 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
| ▸ | XDH | P47989 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | PPIA | P62937 | 1/20 | 0.32 |
| ▸ | CTSG | P08311 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6589009 | 0.97 | MRGPRX4 (0.37) | MRGPRX4SLC6A9APPPTGER1HCRTR1 | |
| SCHEMBL6591925 | 0.94 | MRGPRX4 (0.35) | MRGPRX4SLC6A9APPPTGER1HCRTR1 | |
| SCHEMBL6592295 | 0.94 | MRGPRX4 (0.35) | MRGPRX4SLC6A9APPPTGER1HCRTR1 | |
| SCHEMBL6589725 | 0.93 | MRGPRX4 (0.34) | MRGPRX4SLC6A9APPPTGER1HCRTR1 | |
| SCHEMBL6591887 | 0.93 | MRGPRX4 (0.38) | MRGPRX4SLC6A9APPPTGER1HCRTR1 | |
| SCHEMBL6594261 | 0.92 | MRGPRX4 (0.38) | MRGPRX4SLC6A9APPPTGER1HCRTR1 | |
| SCHEMBL6591101 | 0.89 | MRGPRX4 (0.39) | MRGPRX4SLC6A9PTGER1HCRTR1HCRTR2 | |
| SCHEMBL6590066 | 0.88 | MRGPRX4 (0.38) | MRGPRX4SLC6A9APPPTGER1HCRTR1 | |
| SCHEMBL6592027 | 0.85 | PLAU (0.34) | MRGPRX4PTGER1FFAR1 | |
| SCHEMBL6596445 | 0.82 | PLAU (0.34) | MRGPRX4PTGER1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888271-B1 | BENZAMIDINE DERIVATIVES SUBSTITUTED BY AMINO ACID AND HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS | BERLEX LAB (US) | 2004-04-28 | — | — | EP | disclosed |
| US-6242454-B1 | Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants | BERLEX LABORATORIES INC. | 2001-06-05 | — | — | US | disclosed |
| US-6166088-A | CONTROLLING THROMBOSIS | BERLEX LABORATORIES, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| US-6071912-A | INHIBIT HUMAN FACTOR XA AND ARE THEREFORE USEFUL AS PHARMACOLOGICAL AGENTS FOR THE TREATMENT OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY; AMINO-, OXY- AND THIA-SUBSTITUTED TRIAZINES | BERLEX LABORATORIES, INC. (US) | 2000-06-06 | — | — | US | disclosed |
| US-5994375-A | ANTICOAGULANTS | BERLEX LABORATORIES, INC. (US) | 1999-11-30 | — | — | US | disclosed |